Acceptance-based Behavior Therapy for Depression With Psychosis: Results From a Pilot Feasibility Randomized Controlled Trial

Journal of Psychiatric Practice
Brandon A GaudianoIvan W Miller

Abstract

Acceptance-based depression and psychosis therapy (ADAPT), a mindfulness/acceptance-based behavioral activation treatment, showed clinically significant effects in the treatment of depression with psychosis in a previous open trial. The goal of the current study was to further test the feasibility of ADAPT to determine the utility of testing it in a future clinical trial, following a stage model of treatment development. Feasibility was determined by randomizing a small number of patients (N=13) with comorbid depression and psychosis to medication treatment as usual plus enhanced assessment and monitoring versus ADAPT for 4 months of outpatient treatment. Both conditions were deemed acceptable by patients. Differences in between-subjects effect sizes favored ADAPT posttreatment and were in the medium to large range for depression, psychosocial functioning, and experiential avoidance (ie, the target mechanism). Thus ADAPT shows promise for improving outcomes compared with medications alone and requires testing in a fully powered randomized trial.

References

Aug 1, 1984·Journal of Consulting and Clinical Psychology·N S JacobsonG Margolin
Sep 1, 1984·The Journal of Nervous and Mental Disease·W CoryellM Zimmerman
Apr 1, 1996·The American Journal of Psychiatry·W CoryellD Solomon
Dec 13, 1978·Evaluation and Program Planning·D L LarsenT D Nguyen
Dec 29, 2000·Journal of Behavior Therapy and Experimental Psychiatry·G J Devilly, T D Borkovec
May 17, 2001·Schizophrenia Bulletin·K T MueserP R Mueser
Apr 29, 2003·The Journal of Clinical Psychiatry·Anthony J Rothschild, Suzanne E Duval
Oct 27, 2004·The Journal of Nervous and Mental Disease·Matthew T TullLizabeth Roemer
Apr 6, 2005·Archives of General Psychiatry·Steven D HollonRobert Gallop
May 17, 2005·Behaviour Research and Therapy·Brandon A Gaudiano, James D Herbert
Jul 5, 2005·European Archives of Psychiatry and Clinical Neuroscience·Heinz Häfner
Nov 23, 2005·Behaviour Research and Therapy·Steven C HayesJason Lillis
May 3, 2006·Archives of General Psychiatry·Helena Chmura KraemerJerome A Yesavage
Jun 7, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·A John RushT Michael Kashner
Dec 23, 2006·Clinical Psychology Review·Pim CuijpersLisanne Warmerdam
Apr 26, 2007·Journal of Clinical Psychology·Frances ShawyerDavid Copolov
Feb 9, 2008·Behaviour Research and Therapy·Lars-Göran Ost
Jan 15, 2009·Psychotherapy and Psychosomatics·Mark B PowersPaul M G Emmelkamp
Dec 19, 2009·PloS One·Gavin AndrewsTevik Bedirhan Ustun
Dec 26, 2009·Journal of Behavior Therapy and Experimental Psychiatry·Matthieu VillatteGwenolé Loas
Mar 8, 2011·Behaviour Research and Therapy·Eliot GoldstoneBen Ong
Jul 13, 2011·Behavior Modification·Hilary MairsPhilip Keeley
Oct 7, 2011·Behaviour Research and Therapy·Ross WhiteGordon Mitchell
Apr 18, 2012·Journal of Consulting and Clinical Psychology·Joshua K Swift, Roger P Greenberg
Nov 10, 2012·Behavioural and Cognitive Psychotherapy·Neil ThomasLisa J Phillips
Aug 21, 2013·Schizophrenia Research·Bassam KhouryKarine Paquin
Jul 6, 2014·Clinical Neuropharmacology·Min-Jing LeeYu Lee
Dec 31, 2014·Psychotherapy and Psychosomatics·Jacqueline G L A-TjakPaul M G Emmelkamp

❮ Previous
Next ❯

Citations

Jan 11, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Pim CuijpersToshi A Furukawa
Nov 9, 2016·Disability and Rehabilitation·Stefano FedericiJuan V Luciano
Oct 2, 2020·Behaviour Research and Therapy·Craig SteelMark van der Gaag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.